Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology Group.
Willems P, Verhagen O, Segeren C, Veenhuizen P, Guikema J, Wiemer E, Groothuis L, Jong TB, Kok H, Bloem A, Bos N, Vellenga E, Mensink E, Sonneveld P, Lokhorst H, van Der Schoot E, Raymakers R. Willems P, et al. Among authors: sonneveld p. Blood. 2000 Jul 1;96(1):63-70. Blood. 2000. PMID: 10891431 Free article.
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.
Löwenberg B, Suciu S, Archimbaud E, Ossenkoppele G, Verhoef GE, Vellenga E, Wijermans P, Berneman Z, Dekker AW, Stryckmans P, Schouten H, Jehn U, Muus P, Sonneveld P, Dardenne M, Zittoun R. Löwenberg B, et al. Among authors: sonneveld p. Blood. 1997 Oct 15;90(8):2952-61. Blood. 1997. PMID: 9376575 Free article. Clinical Trial.
[Multiple myeloma; treatment in the year 1998].
Lokhorst HM, Sonneveld P, Wijermans PW, Segeren CM. Lokhorst HM, et al. Among authors: sonneveld p. Ned Tijdschr Geneeskd. 1998 Jul 11;142(28):1596-602. Ned Tijdschr Geneeskd. 1998. PMID: 9763840 Review. Dutch.
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
Lokhorst HM, Sonneveld P, Cornelissen JJ, Joosten P, van Marwijk Kooy M, Meinema J, Nieuwenhuis HK, van Oers MH, Richel DJ, Segeren CN, Veth G, Verdonck LF, Wijermans PW. Lokhorst HM, et al. Among authors: sonneveld p. Bone Marrow Transplant. 1999 Feb;23(4):317-22. doi: 10.1038/sj.bmt.1701574. Bone Marrow Transplant. 1999. PMID: 10100574 Clinical Trial.
Intensive treatment for multiple myeloma: where do we stand?
Lokhorst HM, Sonneveld P, Verdonck LF. Lokhorst HM, et al. Among authors: sonneveld p. Br J Haematol. 1999 Jul;106(1):18-27. doi: 10.1046/j.1365-2141.1999.01406.x. Br J Haematol. 1999. PMID: 10444158 Free article. Review. No abstract available.
A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma; a prospective randomised phase III study.
van Agthoven M, Segeren CM, Buijt I, Uyl-de Groot CA, van der Holt B, Lokhorst HM, Sonneveld P. van Agthoven M, et al. Among authors: sonneveld p. Eur J Cancer. 2004 May;40(8):1159-69. doi: 10.1016/j.ejca.2004.01.019. Eur J Cancer. 2004. PMID: 15110879 Clinical Trial.
Inhibitors of multidrug resistance.
Sonneveld P, Wiemer E. Sonneveld P, et al. Curr Opin Oncol. 1997 Nov;9(6):543-8. doi: 10.1097/00001622-199711000-00009. Curr Opin Oncol. 1997. PMID: 9370075 Review.
618 results